Rapport Therapeutics RAPP
NASDAQ RAPP
$25.93 -0.60 (-2.26%)
At close: Oct 23, 2026 · 4:00 PM EDT

Rapport Therapeutics (RAPP) Purchase of Investments (2024 - 2026)

Updated

Analysis

Rapport Therapeutics (RAPP) Purchase of Investments (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Purchased (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 307.00 Mn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 919.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 834.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 148.00 Mn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 46.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 42.00 Mn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.54 Bn
10 Rapport Therapeutics 1.24 Bn 426.24 Mn - 39.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.67 Mn
Mar 31, 2026 30.37 Mn
Dec 31, 2025 197.07 Mn
Sep 30, 2025 101.62 Mn
Jun 30, 2025 12.86 Mn
Mar 31, 2025 43.24 Mn
Dec 31, 2024 84.56 Mn
Sep 30, 2024 109.74 Mn
Jun 30, 2024 138.43 Mn
Mar 31, 2024 44.80 Mn
API Access

Rapport Therapeutics Purchase of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=purchase-of-investments&ticker=RAPP&period=max&api_key=YOUR_API_KEY